• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Correspondence
Correspondence on Letter regarding “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
Moon Haeng Hur, Yoon Jun Kim
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine
Correspondence :  Yoon Jun Kim ,
Tel: +82-2-2072-2228, Fax: +82-2-743-6701, Email: yoonjun@snu.ac.kr
Received: October 25, 2024   Accepted: November 1, 2024
KeyWords: Liver cancer; Portal vein tumor thrombosis; Yttrium-90 radioembolization; Systemic therapy
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 228 View
  • 13 Download
Related articles

Correspondence on letter to the editor regarding “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma”

Correspondence on Editorial regarding “Genetically modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”

Reply to: Correspondence on Editorial regarding “Genetically modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”

Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Correspondence on Letter regarding “Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors”

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1704
TOTAL : 2235733
Close layer